| 注册
首页|期刊导航|生物技术通报|小分子化合物诱导细胞重编程研究进展

小分子化合物诱导细胞重编程研究进展

顾珊 赵高平 李喜和

生物技术通报2018,Vol.34Issue(1):79-83,5.
生物技术通报2018,Vol.34Issue(1):79-83,5.DOI:10.13560/j.cnki.biotech.bull.1985.2017-0613

小分子化合物诱导细胞重编程研究进展

Research Progress on Cell Reprogramming Induced by Small Molecule Compounds

顾珊 1赵高平 2李喜和1

作者信息

  • 1. 内蒙古大学蒙古高原动物遗传资源研究中心,呼和浩特 010021
  • 2. 内蒙古赛科星家畜种业与繁育生物技术研究院有限公司,呼和浩特 011517
  • 折叠

摘要

Abstract

Cell reprogramming refers to the transformation of gene expression within a cell from one type to another,and that is defined as the converting process of somatic cells to pluripotent or totipotent stem cell by differentiation or to another type of somatic cells by transdifferentiation under certain conditions. Cell reprogramming provides infinite cell resources for clinical patient-specific cell therapy. It can be achieved by somatic cell nuclear transfer,transfecting specific transcription factor,and induction with small molecule compounds. However,the somatic nuclear transfer technique is thought to have ethical issues because of using oocytes ;and the integration of transcription factor into the host genome leads to gene mutations,which greatly limits their clinical application. Small molecule compounds are easy to be synthesized,have fine cell permeability and flexible biological effects. The use of small molecule compounds to induce cell reprogramming avoids the ethical issues from nuclear transfer the potential harm from gene manipulation. At present,the small molecule compounds are used to induce safer iPSCs(induced pluripotent stem cells),ciCMs(chemically induced functional cardiomyocyte cells),and ciNSLCs(chemical-induced neural stem cell-like cells)from somatic cells. Here we summarize different kinds of cell identity conversions induced by small molecule compounds,referring to induced pluripotent stem cells,induced extended pluripotent stem cells and induced cell transdifferentiation,and finally prospect the future development of induction by small molecule compounds,the purpose is to provide reference for future research in this field.

关键词

细胞重编程/细胞转分化/小分子化合物

Key words

cell reprogramming/cell transdifferentiation/small molecule compound

引用本文复制引用

顾珊,赵高平,李喜和..小分子化合物诱导细胞重编程研究进展[J].生物技术通报,2018,34(1):79-83,5.

基金项目

国家自然科学基金项目(31560335) (31560335)

生物技术通报

OA北大核心CSCDCSTPCD

1002-5464

访问量0
|
下载量0
段落导航相关论文